Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
52.96
-0.27 (-0.51%)
At close: Oct 24, 2025, 4:00 PM EDT
53.09
+0.13 (0.25%)
After-hours: Oct 24, 2025, 7:32 PM EDT
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.13B | 12.28B | 3.08B |
| Mar 31, 2025 | 32.91B | 11.27B | 2.93B |
| Dec 31, 2024 | 32.12B | 10.13B | 2.90B |
| Sep 30, 2024 | 30.79B | 8.54B | 2.72B |
| Jun 30, 2024 | 29.96B | 7.53B | 2.62B |
| Mar 31, 2024 | 28.36B | 6.97B | 2.64B |
| Dec 31, 2023 | 26.96B | 6.47B | 2.67B |
| Sep 30, 2023 | 25.05B | 5.58B | 2.71B |
| Jun 30, 2023 | 24.05B | 4.35B | 2.90B |
| Mar 31, 2023 | 22.88B | 3.31B | 3.07B |
| Dec 31, 2022 | 21.69B | 2.62B | 3.19B |
| Sep 30, 2022 | 20.67B | 2.15B | 3.17B |
| Jun 30, 2022 | 19.51B | 1.85B | 3.08B |
| Mar 31, 2022 | 18.53B | 1.59B | 3.04B |
| Dec 31, 2021 | 17.59B | 1.31B | 2.98B |
| Sep 30, 2021 | 16.42B | 1.11B | 2.95B |
| Jun 30, 2021 | 15.65B | 966.19M | 2.99B |
| Mar 31, 2021 | 15.34B | 880.70M | 2.96B |
| Dec 31, 2020 | 15.10B | 882.72M | 2.98B |
| Sep 30, 2020 | 15.63B | 939.61M | 3.11B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.